Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide. Its prescription medicines include weight management, andrology, cardiovascular, respiratory, neurology, cardiovascular, metabolism, obstetrics and gynecology, antibiotic, immunology, and anti-cancer drugs. The company also provides nutrition and baby care products, such as milk under the Karihome brand name; and healthcare supplements for liquid nutrition, regular blood lipids, L-arginines, agile movements, and improved sleep qualities under the Nutrifuel brand name. In addition, …
Last updated
14 Aug 2026
Exchange
Taipei Exchange · TWO
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
TWD
Market capitalisation
4,267,957,504
Fair value reference
41.52
Next-week expectancy
Undecided · 49.40%
Executive chart read
Over the latest 12 completed weeks ending 2026-08-14, 4120 rose 20.34%, moving from 40.88 to 49.20. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 11 of the last 12 weeks. Relative Strength is -19.57 and has improved across the 12-week window. Market Dynamics is 1.34 on the latest week. Next-week expectancy is undecided at 49.40% based on similar historical setup states.
Week Ending
14 Aug 2026
Latest Close
49.20
12-Week Change
20.34%
Trend Signal
Active
Next-Week Expectancy
Undecided 49.40%
Signal Weeks
11 of 12
Weekly Price
Weekly Close
Trend Line
Fair Value
Activity Lines
Chart Panels
Choose up to 5 panels. Drag panel headers to reorder.
Price Action
Up Week
Down Week
Trend Line
Pivotal Level / Support
Volume
Range
Sharemaestro Range
Where price is trading
The fitted range, accepted trading area and strongest price levels are calculated automatically from completed weekly market data.
Current stateAbove the trend range
52-week position
74.3%
Low to high
Accepted price
48.84
Latest versus accepted: 0.73%
Fitted direction
Sideways
-0.06% per week
Range pressure
90/100
Upper pressure
Range condition
Normal
1.24× normal range
Range pressureCurrent range pressure · 50 is balanced
Weekly closeFitted rangeActivity ribbonEstimated activity at priceAutomatic level
Automatic structure
Strongest price levels
Support47.68
From price
-3.1%
Evidence
71/100
Touches
2
Support48.84
From price
-0.7%
Evidence
96/100
Touches
4
Resistance49.77
From price
1.2%
Evidence
62/100
Touches
1
Resistance51.87
From price
5.4%
Evidence
43/100
Touches
1
Current reading
What the range shows
Current positionAbove the trend range
Price is at 74.3% of its latest 52-week range.
Fitted directionSideways
The fitted centre line is moving -0.06% per week.
Range pressureUpper pressure
The current pressure reading is 90/100; 50 is balanced.
Next structural level49.77
Resistance is 1.2% from the latest close with 62/100 evidence strength.
Point & Figure
Price structure · volume at price
Point & Figure market structure
Each X marks a rising price box and each O marks a falling price box. Time is removed from the horizontal scale so reversals, breakouts and areas of heavy trading stand out.
MethodAdaptive scale
Smart Money
Close Price
Trend Line
Demand Threshold Line
Reversal Risk Level
Market Dynamics
Volume Action
Price Action
Market Dynamics
Rate of Change
0-1.5TopBottomRawCloseMarket Strength30W ROCVolume SupportPrice Action RibbonBuyFlip UpFlip Down
Price Cycle
Market Price Cycle
PC Activity Line
PC Trend Line
Next-State Map
Next-State Map
Historical one-week transition paths from similar completed-week states.
SMI
Weekly Close
Trend Line
Fair Value
Activity Lines
SMI
Chart Summary
Key Points
Week Ending
14 Aug 2026
Latest Close
49.20
12-Week Change
20.34%
Trend Signal
Active
Next-Week Expectancy
Undecided 49.40%
Signal Weeks
11 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
-19.57
Market Dynamics
1.34
Over the latest 12 completed weeks ending 2026-08-14, 4120 rose 20.34%, moving from 40.88 to 49.20. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 11 of the last 12 weeks. Relative Strength is -19.57 and has improved across the 12-week window. Market Dynamics is 1.34 on the latest week. Next-week expectancy is undecided at 49.40% based on similar historical setup states.
Industry Peers
Taiwan equities in Drug Manufacturers - Specialty & Generic
Search by ticker symbol or company name and select a result to open its chart.
Sharemaestro
Send a message
Ask a question, report a correction, or send a publisher/support note.
Cookie preferences
Essential cookies keep Sharemaestro secure and working. Choose whether we may use optional persistent analytics and advertising technologies. Limited cookieless server measurement continues for aggregate traffic and security.
